期刊文献+

凝血因子Ⅸ基因剔除小鼠近交系的建立 被引量:1

Establishing inbred strain of coagulation factor Ⅸ-knockout mouse
下载PDF
导出
摘要 目的 :建立可稳定遗传、临床症状显著的凝血因子 (F )基因剔除小鼠近交系。 方法 :以 PCR扩增检测小鼠尾组织 DNA,一期法检定小鼠血浆 F 活性和血浆凝血酶原时间 (PT)、白陶土部分凝血活酶时间 (KPTT)值 ;取以上结果为全阳性的小鼠以选优法进行全同胞兄妹交配 ,每代选用第一胎小鼠留种 ,第 8代开始筛选纯合子。 结果 :F8代 F 基因剔除小鼠PCR检测阳性率 92 % ,到 F1 2 代小鼠阳性率达 10 0 % ;F 活性 (2 .4 7± 1.75 ) %较正常小鼠 (14 8.18± 4 6 .98) %明显降低 (P<0 .0 1) ;F 基因剔除小鼠已近交培育到第 12代 ,遗传性状稳定 ,并有自发出血倾向。结论 :成功建立了纯合子 F 基因剔除小鼠近交系 ,该小鼠符合人血友病 Objective:To establish a inbred strain of the coagulation factor Ⅸ knockout mice with stable heredity and obvious clinical symptoms. Methods:The genomic DNA from tail tissue of mice were analyzed by PCR. F Ⅸ activity plasma prothrombin time and kadin partial thromboplastin time were measured by one stage method.The positive mice were mated with brother sister by optimum seeking method.The stocks of every generation were selected from first born mice.The homogeneous mice were selected after F 8. Results: PCR analysis of F Ⅸ mice(F 8) was 92% positive and F Ⅸ mice(F 12 ) was 100% positive. F Ⅸ activity (2.47±1.75)% was lower than normal mice (148.18±46.98)%. F Ⅸ knockout mice were developed 12th generation and there were spontaneous bleeding in the factor Ⅸ knockout mice. Conclusion:The result showed that the coagulation F Ⅸ knockout mice inbred strain were established and exhibited a phenotype similar to human hemophilia B.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2003年第2期200-202,共3页 Academic Journal of Second Military Medical University
基金 上海市科学技术发展基金 (9949190 3 2 )
关键词 凝血因子Ⅸ基因剔除小鼠 近交系 动物模型 coagulation factorⅨ knockout mice inbred strain animal model
  • 相关文献

参考文献3

二级参考文献22

  • 1Lin Huifeng,Blood,1997年,90卷,10期,3962页
  • 2Lin H F,Blood,1997年,90卷,1期,3962页
  • 3Wang L,Proc Nat Acad Sci USA,1997年,94卷,21期,11563页
  • 4J. L. Xue,D. R. Lu,J. M. Zhou.Stage I clinical trial of fibroblast gene therapy for hemophilia B. Science in China . 1993
  • 5H. W. Wang,C. X. Li.High expression of hFIX cDNA in myoblasts C2C12 cells and CH3 mice. Science in China . 1997
  • 6Ory D S,Neugeboren B A,Mulligan R C,et al.A stablehuman-derived packaging cell line for production of high-titerretrovirus/vesicular stomatitis pseudotyped virus. Proceedings of the National Academy of Sciences of the United States of America . 1996
  • 7D. B. Kohn,R. Parkman.Gene therapy for newborns. The FASEB Journal . 1997
  • 8T. VandenDriessche,V. Vanslembrouck,I. Goovaerts.Long-term expression of human coagulation factor VIII and correction of hemophilia A afterin vivo retroviral gene transfer in factor VIII-dedicient mice. Proc. Nalt. Acad. Sci. USA . 1999
  • 9A. Miyanhokara,S. K. Yee,B. P. Laporte.Efficientin vivo transduction of the neonatal mouse liver with pseudotyped retroviral vector. Gene Therapy . 1995
  • 10M. Iepeda,J. M. Wilso.Neonatal cotton rats do not exhibit destructive immune response to adenoviral vectors. Gene Therapy . 1996

共引文献8

同被引文献14

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部